Publications by authors named "C Mermutluoglu"
Objective: We are still in search of new therapeutic options for COVID-19 to prevent new infections, enable fast recovery and reduce the long-lasting symptoms or sequelae. This study aimed to investigate the short- and long-term effects of inhaled aviptadil on hospitalized, adult COVID-19 patients.
Methods: A multicenter, prospective, placebo-controlled, comparative, randomized, double-blind clinical trial was conducted.
Extrapulmonary tuberculosis (EPTB) is an important public health problem due to its diverse clinical presentations, diagnostic complexities, and significant impact on patient outcomes and public health. Our study aimed to understand the sociodemographic, clinical, and laboratory characteristics as well as diagnostic and treatment modalities of adult patients with EPTB. This is a multicentric retrospective study that covers patients with EPTB cases followed up from January 2015 to December 2022 among tuberculosis (TB) dispensaries and Infectious Diseases and Clinical Microbiology clinics of 15 hospitals located in various regions of Turkey.
View Article and Find Full Text PDFBackground And Aim: This study aimed to define the relapse frequency and risk determinants in chronic hepatitis B (CHB) patients who discontinued nucleoside analog (NA) treatment, were HBeAg-negative, and had achieved both a virological and biochemical response.
Materials And Methods: This retrospective cohort study reviewed patients with HBeAg-negative CHB who received antiviral therapy for at least 65 months between January 1, 2013, and December 31, 2020. These patients discontinued treatment after demonstrating a biochemical and virological response and were evaluated at 6, 12, and 24 months post-treatment discontinuation.
Introduction: The aim of this national, multicenter, cross-sectional, retrospective chart review study was to determine the proportion of patients in Turkey who received hepatitis C virus (HCV) treatment after receiving positive anti-HCV results during HCV screening.
Methodology: Data related to patients' demographics, laboratory results, time interval from obtaining a positive anti-HCV result to treatment initiation, specialty of the physician requesting anti-HCV screening, and type of hospital were analyzed.
Results: Among 1,000 patients who received a positive anti-HCV result, 50.
Article Synopsis
- The study investigated the vaccination status and risk factors for ICU support among inpatients with breakthrough COVID-19 infections, categorizing them as fully or partially vaccinated.
- A total of 516 patients were analyzed, revealing that hypertension, diabetes, and coronary artery disease were common comorbidities, with fully vaccinated patients showing a significantly lower need for ICU support.
- The findings suggest that older age, specific health conditions, and incomplete vaccination increase the likelihood of requiring ICU care, highlighting the need for ongoing monitoring and booster vaccinations for at-risk populations.